Search results
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 4 days agoVaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 16 hours agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 3 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of...
The FLiRT COVID variants: What are they and are they more contagious?
Reuters· 16 hours agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
Novavax Unusual Options Activity For May 23 - Novavax (NASDAQ:NVAX)
Benzinga· 1 day agoThe company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly ...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters via AOL· 5 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 3 days agoNovavax and Inovio have soared since 2024 started. Which of these two biotechs can outperform the other moving forward? Let's take a look. NVAX data by...
This Stock Just More Than Doubled in 1 Day: Is It a Buy? | The Motley Fool
The Motley Fool· 6 days agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus ...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 6 days agoVaccine maker Novavax (NASDAQ: NVAX) isn't dead in the water after all. Though the past 18 months...
Is Novavax Stock a Buy?
Motley Fool via Yahoo Finance· 7 days agoRival Moderna announced earlier this year that it would be pausing plans to build a plant in Kenya for vaccine development due to a drop in demand for...
